Medical Biotechnology in Germany 2011 – Biopharmaceuticals: Economic Data and Benefit of Personalized Medicine

The new report “Medical Biotechnology in Germany 2010 – Benefit of Biopharmaceuticals for Children” is now available. It was provided by The Boston Consulting Group for vfa bio. This yearly report is the only one recording all activities within medical biotechnology in Germany – ranging from startup to big companies.
read on

Medical Biotechnology has weathered the economic crisis well. This was announced at the launch of the Industry Report “Medical Biotechnology 2010”. The report was produced by the Boston Consulting Group. The study provides an overview of the German biopharmaceutical industry, and analyzes the medical biotech activities of small and medium-sized companies, as well as large corporations.
read on

The Boston Consulting Group has provided the new report “Medical Biotechnology in Germany 2009 – Economic Data for Biopharmaceuti-cals and Therapeutic Progress through Antibodies” for vfa bio. This yearly report is the only one recording all activities within medical biotechnology in Germany – ranging from startup to big companies.
read on